Tokio Marine Asset Management CO LTD Gilead Sciences, Inc. Transaction History

Tokio Marine Asset Management CO LTD

$1.96 Billion
Q1 2024

A detailed history of Tokio Marine Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tokio Marine Asset Management CO LTD holds 30,603 shares of GILD stock, worth $2.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

30,603

Previous 31,811 3.8%

Holding current value

$2.1 Million

Previous $2.58 Million 13.04%

% of portfolio

0.11%

Previous 0.14%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$71.58 - $87.29 $86,468 - $105,446	-1,208 Reduced 3.8%	30,603 $2.24 Million
Q4 2023 Feb 02, 2024	BUY	$73.27 - $83.09 $121,921 - $138,261	1,664 Added 5.52%	31,811 $2.58 Million
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $113,128 - $123,425	1,530 Added 5.35%	30,147 $2.26 Million
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $133,549 - $152,331	1,757 Added 6.54%	28,617 $2.21 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $278,393 - $317,176	3,601 Added 15.48%	26,860 $2.23 Million

Q4 2022 Jan 26, 2023	BUY	$62.32 - $89.47 $133,302 - $191,376	2,139 Added 10.13%	23,259 $0
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $57,337 - $65,493	963 Added 4.78%	21,120 $1.3 Million
Q2 2022 Aug 09, 2022	BUY	$57.72 - $65.01 $190,129 - $214,142	3,294 Added 19.53%	20,157 $1.25 Million
Q1 2022 May 13, 2022	SELL	$57.92 - $72.58 $121,400 - $152,127	-2,096 Reduced 11.06%	16,863 $1 Million
Q4 2021 Jan 26, 2022	BUY	$64.88 - $73.64 $16,544 - $18,778	255 Added 1.36%	18,959 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $55,911 - $60,322	826 Added 4.62%	18,704 $1.31 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $35,860 - $39,182	-565 Reduced 3.06%	17,878 $1.23 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $594,180 - $677,959	-9,903 Reduced 34.94%	18,443 $1.19 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $41,467 - $47,250	732 Added 2.65%	28,346 $1.65 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $3.12 Million - $3.92 Million	-50,189 Reduced 64.51%	27,614 $1.75 Million
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $1.95 Million - $2.27 Million	-26,995 Reduced 25.76%	77,803 $5.99 Million
Q1 2020 May 12, 2020	BUY	$62.63 - $80.22 $73,151 - $93,696	1,168 Added 1.13%	104,798 $7.84 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $31,919 - $35,110	518 Added 0.5%	103,630 $6.73 Million
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $1.79 Million - $1.98 Million	28,634 Added 38.45%	103,112 $6.54 Million
Q2 2019 Jul 25, 2019	BUY	$61.87 - $69.38 $304,586 - $341,557	4,923 Added 7.08%	74,478 $5.03 Million
Q1 2019 Apr 25, 2019	BUY	$62.53 - $70.05 $31,515 - $35,305	504 Added 0.73%	69,555 $4.52 Million
Q4 2018 Feb 04, 2019	BUY	$60.54 - $79.0 $19,857 - $25,912	328 Added 0.48%	69,051 $4.32 Million
Q3 2018 Oct 23, 2018	BUY	$71.28 - $78.92 $3,136 - $3,472	44 Added 0.06%	68,723 $5.31 Million
Q2 2018 Jul 18, 2018	SELL	$64.88 - $75.68 $38,019 - $44,348	-586 Reduced 0.85%	68,679 $4.87 Million
Q1 2018 May 03, 2018	SELL	$72.84 - $88.8 $211,454 - $257,786	-2,903 Reduced 4.02%	69,265 $5.22 Million
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $191,678 - $225,002	-2,694 Reduced 3.6%	72,168 $5.17 Million
Q3 2017 Oct 30, 2017	SELL	$72.11 - $85.47 $741,795 - $879,229	-10,287 Reduced 12.08%	74,862 $6.07 Million
Q2 2017 Jan 11, 2018	SELL	N/A	-8,759 Reduced 9.33%	85,149 $6.03 Million
Q1 2017 Jan 11, 2018	BUY	N/A	68,255 Added 266.07%	93,908 $6.38 Million
Q4 2016 Jan 11, 2018	SELL	N/A	-9,321 Reduced 26.65%	25,653 $1.84 Million
Q3 2016 Jan 11, 2018	SELL	N/A	-5,122 Reduced 12.77%	34,974 $2.77 Million
Q2 2016 Jan 11, 2018	SELL	N/A	-3,576 Reduced 8.19%	40,096 $3.35 Million
Q1 2016 Jan 11, 2018	BUY	N/A	43,672	43,672 $4.01 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tokio Marine Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Tokio Marine Asset Management CO LTD with notifications on news.

Account

Tokio Marine Asset Management CO LTD Gilead Sciences, Inc. Transaction History